Viromed Medical AG (FRA:VME) Total Operating Expense: €3.15 Mil (TTM As of Dec. 2025)


FRA:VME Viromed Medical AG FRA:VME
22 GF Score
Price €6.80
! 5 Warning Signs
View Full Analysis

What is Viromed Medical AG Total Operating Expense?

Viromed Medical AG FRA:VME +0.74% 22 Total Operating Expense is €3.15 Mil as of Dec. 2025. GuruFocus rates FRA:VME with a GF Score™ of 22/100. The stock has 5 warning signs investors should review.

Viromed Medical AG's Total Operating Expense for the six months ended in Dec. 2025 was €2.87 Mil. Viromed Medical AG's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €3.15 Mil.

Viromed Medical AG Total Operating Expense Related Terms

Viromed Medical AG Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Viromed Medical AG's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Viromed Medical AG Total Operating Expense Chart

Viromed Medical AG Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
0.01 0.16 0.36 3.21 3.15

Viromed Medical AG Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Operating Expense Get a 7-Day Free Trial Premium Member Only 0.18 0.16 3.05 0.28 2.87
FRA:VME
22GF Score
Viromed Medical AG FRA:VME
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Viromed Medical AG Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.15 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €3.15 Mil mean?
Viromed Medical AG (FRA:VME) has a Total Operating Expense of €3.15 Mil as of Dec. 2025. Total operating expense is the primary recurring expense associated with central operations. View historical data on Viromed Medical AG and its competitors.
Is Viromed Medical AG's Total Operating Expense too high?
Viromed Medical AG's current Total Operating Expense is €3.15 Mil. Overall, Viromed Medical AG has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Viromed Medical AG's Total Operating Expense compare to ABT and SYK?
Viromed Medical AG's Total Operating Expense of €3.15 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Viromed Medical AG and its competitors. Viromed Medical AG's current Total Operating Expense is €3.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viromed Medical AG stock overvalued right now?
Viromed Medical AG (FRA:VME) has a current Total Operating Expense of €3.15 Mil. The current Total Operating Expense is €3.15 Mil. Viromed Medical AG's overall GF Score™ is 22/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Viromed Medical AG (FRA:VME), the current Total Operating Expense is €3.15 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Viromed Medical AG Business Description

Other Exchanges VME:Germany
Address Hauptstrasse 105, Rellingen, Pinneberg, SH, DEU, 25462
Viromed Medical AG is a medical technology company. It focuses on using cold plasma technology to develop medical solutions that protect people from viruses, bacteria, and multi-resistant germs. Viromed's product offerings include ViroCAP, a medical device based on cold plasma technology for treating wounds; ViroCAP derma-podo, a medical device that uses cold atmospheric plasma therapy for skin and foot care; and a Raumluftentkeimer. The company covers the entire value chain from research and development to production, logistics, marketing, and sales of its products.
22GF Score

Get the complete analysis for FRA:VME

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.80
Price